Anzeige
Mehr »
Login
Freitag, 10.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
GameStop 2.0? ...alle Anzeichen für den nächsten großen Short Squeeze!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
193 Leser
Artikel bewerten:
(1)

iC Consult Group GmbH: iC Consult Welcomes Hila Meller as Chief Revenue Officer

Finanznachrichten News

Bringing Visionary Leadership to Accelerate Global Success

MUNICH, DE / ACCESSWIRE / January 9, 2025 / iC Consult Group, the leading independent consultancy and managed services provider for Identity & Access Management (IAM) and Identity-driven Cybersecurity, is thrilled to announce the appointment of Hila Meller as Chief Revenue Officer (CRO), effective 01. January 2025. This strategic addition to iC Consult's global leadership team reflects the company's ongoing commitment to growth, innovation, and leadership in the IAM space.

With over 25 years of experience in cybersecurity and Identity & Access Management, Hila brings unparalleled expertise to iC Consult. Her impressive career spans senior leadership roles in globally recognized organizations, including her tenure as President and CRO at Fingerprints AB, a leader in biometric solutions, and as Global CRO at BT Security, a leading managed security services provider. Hila's proven track record includes transformative leadership positions at HP, DXC, and CA Technologies.

Hila is widely regarded as a thought leader in cybersecurity. She has been recognized in the book "Women Know Cyber: 150 Fascinating Females Fighting Cyber Crime" and is frequently sought after as a keynote speaker at global conferences. Beyond her professional achievements, she co-founded Leading Cyber Ladies, a global movement dedicated to promoting diversity in the cyber industry.

"I am incredibly excited to join iC Consult, a company I've worked with in the past, and look at its innovation and excellence in the IAM industry. This is an incredibly dynamic time for the sector, driven by the evolution of Zero Trust, cloud adoption, and user experience enhancements. I am eager to work with the talented team at iC Consult to drive growth and help our clients navigate these exciting developments in identity security," says Hila Meller, the newly appointed CRO of iC Consult.

Volker Witzel, CEO of iC Consult Group, adds: "We are delighted to welcome Hila Meller to our executive leadership team. Her extensive experience and visionary leadership in cybersecurity and IAM perfectly align with our mission to deliver Identity-driven Cybersecurity solutions. With Hila's expertise and energy, we strengthen our ability to accelerate growth at a global scale and continue delivering innovative solutions to our clients."

As iC Consult continues to lead in the IAM space, Hila's appointment underscores the company's dedication to driving excellence and shaping the future of identity security.

About iC Consult

iC Consult is the world's leading independent consultancy, systems integrator, and managed services provider for identity-driven cybersecurity with more than 850 employees worldwide. Committed to excellence and innovation, iC Consult provides customers with next-level cyber security solutions using best-in-class IAM technology. Its service portfolio covers Managed Services for IAM, including advisory, architecture, implementation, integration, support, and operations. Headquartered in Germany, iC Consult has offices in Switzerland, Austria, France, Belgium, Spain, Bulgaria, the UK, the U.S., Canada, India, and China. The world's largest brands trust in iC Consult's expertise to secure and manage their most valuable assets: their identities.

Contact Information

Ulli Rottmueller
VP of Marketing & Partner Management
ulli.rottmueller@ic-consult.com

.

SOURCE: iC Consult Group GmbH



View the original press release on accesswire.com

© 2025 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.